Corporate news 22 Apr, 2021NovAliX appoints Dr. Jerome Guillemont as head of drug discovery, alongside two new directors
Events 18 Mar, 2021Exciting program and speakers for the 2nd NovAliX Conference “Biophysics in Drug Discovery”
Corporate news 26 Jan, 2021NovAliX partners with Chemical.AI to develop artificial intelligence toolkit for drug discovery
Events 18 Nov, 2020Large audience at a dynamic first virtual NovAliX Conference “Biophysics in Drug Discovery”
Corporate news 01 Oct, 2020NovAliX to implement research operations in Val de Reuil and to provide chemistry research services to Janssen
30 Apr, 2021Remarkably Efficient Iridium Catalysts for Directed C(sp2)–H and C(sp3)–H Borylation of Diverse Classes of Substrates
21 Apr, 2021Human rhinovirus infection blocks SARS-CoV-2 replication within the respiratory epithelium: implications for COVID-19 epidemiology
25 Mar, 2021Electrochemically Enabled, Nickel-Catalyzed Dehydroxylative Cross-Coupling of Alcohols with Aryl Halides
25 Feb, 2021Interrupting the Barton–McCombie Reaction: Aqueous Deoxygenative Trifluoromethylation of O-Alkyl Thiocarbonates
